BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 20, 2012
View Archived Issues
Sangamo cell therapy increases CD4+ T-cell counts in patients with HIV
Read More
Novacta Biosystems develops novel candidate antibacterials
Read More
Phase I trial assesses interaction between diabetes therapies
Read More
Novel first-in-human data presented on Medimmune cancer immunotherapy
Read More
New data highlight role of lymphopoietin in chronic rhinosinusitis with nasal polyps
Read More
U.S. study links SNPs to complications after subarachnoid hemorrhage
Read More
Cartagenia enters partnership for rare epilepsy syndromes
Read More
Merck & Co. enters into collaboration to create new institute
Read More
Ampio provides update on Optina trial
Read More
Once-daily tramadol capsule launched in Canada for chronic pain
Read More
Alnylam launches phase I trial of transthyretin-mediated amyloidosis therapy
Read More
Provectus Pharmaceuticals reports topline phase II data on PH-10
Read More
QRxPharma and Actavis sign new licensing agreement
Read More
CUNY to validate diagnostic antibodies
Read More
Novel GPR124 receptor agonists designed in U.S.
Read More
New potential flu therapies presented
Read More
New nicotinic acetylcholine receptor ligands synthesized
Read More
Boehringer Ingelheim Pharma divulges new MPGES-1 inhibitors
Read More
Santhera reports novel mitochondrial function modulators
Read More
Avaxia receives second NIH grant for oral IBD immunotherapeutic
Read More
Merck & Co. to discontinue development of vernakalant formulation
Read More
AstraZeneca and Targacept give update on TC-5214 development
Read More
First once-daily 24-hour LABA for COPD maintenance launched in U.S.
Read More
Enrollment complete in phase III trials of allergy immunotherapy
Read More
Cellceutix enters collaboration agreement to support Kevetrin development
Read More